Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.

Increased survival of patients aged 0-29 years with osteosarcoma: A period analysis, 1984-2013.
复制标题

0-29 岁骨肉瘤患者的生存率增加:1984-2013 年期间分析

DOI:
10.1002/cam4.1659
复制
发表时间:
2018-08
期刊:
影响因子:
4
通讯作者:
Ma H
Ma H
中科院分区:
医学3区
文献类型:
--
作者:
Wu J;Sun H;Li J;Guo Y;Zhang K;Lang C;Zou C;Ma H

文献摘要

参考文献

被引文献

相似文献

Osteosarcoma is the most common primary malignancy of bone, and typically occurs among children and adolescence. This study aims to evaluate treatment outcomes among children, adolescents and young adults with osteosarcoma over the three decades by the changes in the long‐term relative survival. Osteosarcoma incidence and relative survival data from Surveillance, Epidemiology, and End Results (SEER) registries during 1984‐2013 were analyzed. The survival differences over three decades, age, sex, race, and socioeconomic status (SES) were assessed by comparing Kaplan‐Meier curves. The overall incidence of osteosarcoma kept relatively stable with 0.4 per 100 000 in the three decades with the peak incidence occurring in the aged 10‐19 group. The 10‐year relative survival rate (RSR) increased from 57.7% to 61.0% in the three decades, with the greatest increase in the aged 0‐9 group from 48.2% to 65.7%. The 10‐year RSR improved from 54.1% to 61.5% in males, and from 62.4% to 63.0% in females, respectively, in the three decades. Furthermore, survival dramatically improved from 30% to 60% in the high‐poverty group over the three decades. This study demonstrated that the overall incidence of osteosarcoma remained stable, with an improvement in survival in the three decades. The improved survival was greater in males than in females in the three decades. Furthermore, the survival significantly increased in high‐poverty group, which was attributed to increasing improved health care system and patients with low finance can also have access to receiving effective and consistent treatment without distinction.
DOI: 10.1186/1471-2407-8-22
发表时间: 2008-01-23
期刊: BMC cancer
影响因子: 3.8
作者:
Schnurr C;Pippan M;Stuetzer H;Delank KS;Michael JW;Eysel P
通讯作者: Eysel P
DOI: 10.2105/ajph.93.10.1655
发表时间: 2003-10-01
影响因子: 12.7
作者:
Krieger, N;Chen, JT;Subramanian, SV
通讯作者: Subramanian, SV
DOI: 10.1097/mph.0b013e318230dfea
发表时间: 2011-10-01
影响因子: 1.2
作者:
Betancourt, Joseph R.;Renfrew, Megan R.
通讯作者: Renfrew, Megan R.
DOI: 10.1093/oxfordjournals.aje.a116773
发表时间: 1993-07-01
影响因子: 5
作者:
SILVA, ID;SWERDLOW, AJ
通讯作者: SWERDLOW, AJ
DOI: 10.1002/cncr.24121
发表时间: 2009-04-01
期刊: CANCER
影响因子: 6.2
作者:
Mirabello, Lisa;Troisi, Rebecca J.;Savage, Sharon A.
通讯作者: Savage, Sharon A.